Metronomic therapy of NSCLC with vinorelbine
What is it about?
Metrinomic therapy is underevaluated in lung cancer. Oral drugs like vinorelbine allow continous daily dosing in an outpatient setting. We established a recommended dose and showed preliminary efficacy in heavily pretreated patients with NSCLC
Why is it important?
Metronomic application of daily oral vinorelbine offers a further treatment options in advanced pretreated patients with NSCLC
The following have contributed to this page: Dr. Birgit Edlich and Professor Rudolf M. Huber